Indications and long-term outcomes of preoperative inferior vena caval filters in 111 patients at high risk of pulmonary embolism undergoing major abdominal surgery.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
Aug 2021
Historique:
revised: 23 05 2021
received: 28 03 2021
accepted: 24 05 2021
pubmed: 7 6 2021
medline: 16 9 2021
entrez: 6 6 2021
Statut: ppublish

Résumé

Patients with abdominal cancer requiring major surgical intervention are at high risk of venous thromboembolic events (VTE), particularly pulmonary emboli (PE). A proportion of patients with cancer can present with, or have had, major VTEs prior to definitive surgical treatment. Preoperative percutaneous inferior venal caval filters (IVCF) may reduce the risk of PE. The aim of this study was to assess the indications, complications, retrieval rates, and long-term outcome of IVCFs in patients undergoing major abdominal surgery. This was a retrospective analysis of a prospective IVCF database between 2007 and 2018 of all patients with IVCF insertion prior to major abdominal surgery. The indications for an IVCF, procedural complications and surgical interventions were recorded. Overall, 111 patients had IVCF insertion. IVCF placement failed in one patient with gross abdominal disease. Indications for an IVCF were: prior PE in 65/111 (59%) and major vein thrombus in 42 (38%). Overall, 26/111 (23%) had the IVCF removed at a median of 91 days. In two patients IVCF removal failed. At follow-up of the 85 patients who had the IVCF left in situ, six developed filter-related thrombus and 13 a deep vein thrombosis (DVT). Four patients had a PE with an indwelling IVCF. Preoperative IVCF may reduce perioperative PE in patients at high risk of thrombosis undergoing major abdominal surgery where early anticoagulation is contraindicated. Long-term follow-up of retained IVCF suggests that major problems are infrequent, though further thrombosis may occur and long-term anticoagulation may be needed.

Identifiants

pubmed: 34092012
doi: 10.1111/codi.15767
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1982-1988

Informations de copyright

© 2021 The Association of Coloproctology of Great Britain and Ireland.

Références

Greenfield LJ, McCurdy JR, Brown PP, Elkins RC. A new intracaval filter permitting continued flow and resolution of emboli. Surgery. 1973;73(4):599-606.
Wang SL, Lloyd AJ. Clinical review: inferior vena cava filters in the age of patient-centered outcomes. Ann Med. 2013;45(7):474-81. https://doi.org/10.3109/07853890.2013.832951
PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism. Circulation. 2005;112(3):416-22. https://doi.org/10.1161/CIRCULATIONAHA.104.512834
Bikdeli B, Chatterjee S, Desai NR, Kirtane AJ, Desai MM, Bracken MB, et al. Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70(13):1587-97. https://doi.org/10.1016/J.JACC.2017.07.775
DeYoung E, Minocha J. Inferior vena cava filters: guidelines, best practice, and expanding indications. Semin Intervent Radiol. 2016;33(2):065-70. https://doi.org/10.1055/s-0036-1581088
Grewal S, Chamarthy MR, Kalva SP. Complications of inferior vena cava filters. Cardiovasc Diagn Ther. 2016;6(6):632-41. https://doi.org/10.21037/cdt.2016.09.08
Morales JP, Li X, Irony TZ, Ibrahim NG, Moynahan M, Cavanaugh KJ. Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2013;1(4):376-84. https://doi.org/10.1016/j.jvsv.2013.04.005
Brown JD, Raissi D, Han Q, Adams VR, Talbert JC. Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort. J Am Heart Assoc. 2017;6(9):e006708. https://doi.org/10.1161/JAHA.117.006708
Dixon A, Stavropoulos SW. Improving retrieval rates for retrievable inferior vena cava filters. Expert Rev Med Devices. 2013;10(1):135-41. https://doi.org/10.1586/erd.12.65
Siracuse JJ, Al Bazroon A, Gill HL, Meltzer AJ, Schneider DB, Parrack I, et al. Risk factors of nonretrieval of retrievable inferior vena cava filters. Ann Vasc Surg. 2015;29(2):318-21. https://doi.org/10.1016/j.avsg.2014.08.008
Minocha J, Idakoji I, Riaz A, Karp J, Gupta R, Chrisman HB, et al. Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic. J Vasc Interv Radiol. 2010;21(12):1847-51. https://doi.org/10.1016/j.jvir.2010.09.003
Laws J, Lewandowski R, Ryu R, Desai K. Retrieval of inferior vena cava filters: technical considerations. Semin Intervent Radiol. 2016;33(2):144-8. https://doi.org/10.1055/s-0036-1582119
Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism. Chest. 2008;133(6):381S-453S. https://doi.org/10.1378/chest.08-0656
Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion. Cancer. 2006;106(5):1144-53. https://doi.org/10.1002/cncr.21708
Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol. 2006;13(5):635-44. https://doi.org/10.1245/ASO.2006.03.079
Rottenstreich A, Kalish Y, Kleinstern G, Ben YA, Dux J, Nissan A. Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2017;116(7):914-20. https://doi.org/10.1002/jso.24746
El-Dhuwaib Y, Selvasekar C, Corless DJ, Deakin M, Slavin JP. Venous thromboembolism following colorectal resection. Color Dis. 2017;19(4):385-94. https://doi.org/10.1111/codi.13529
Sarosiek S, Crowther M, Sloan JM. Indications, complications, and management of inferior vena cava filters. JAMA Intern Med. 2013;173(7):513. https://doi.org/10.1001/jamainternmed.2013.343
Kinney TB. Update on inferior vena cava filters. J Vasc Interv Radiol. 2003;14(4):425-40.
Spiegel A, Rettew A, Shaikh B, et al. IVC filter perforation through the duodenum found after years of abdominal pain. Am J Case Rep. 2015;16:292-5. https://doi.org/10.12659/AJCR.893541
Vandy F, Rectenwald JE, Criado E. Late gastrointestinal complications of inferior vena cava filter placement: case report and literature review. Perspect Vasc Surg Endovasc Ther. 2011;23(4):261-4. https://doi.org/10.1177/1531003511409058

Auteurs

Danko Kostadinov (D)

Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Alexios Tzivanakis (A)

Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Gaurang Ubhayakar (G)

Department of Radiology, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Shaheen Dixon (S)

Department of Radiology, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Vincent Helyar (V)

Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Sanjeev Paul Dayal (SP)

Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Faheez Mohamed (F)

Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Thomas Desmond Cecil (TD)

Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Brendan John Moran (BJ)

Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH